.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Fuji
Colorcon
US Army
AstraZeneca
Moodys
Deloitte
Harvard Business School
Cipla
Farmers Insurance

Generated: July 24, 2017

DrugPatentWatch Database Preview

Methoxamine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for methoxamine hydrochloride and what is the scope of methoxamine hydrochloride freedom to operate?

Methoxamine hydrochloride
is the generic ingredient in one branded drug marketed by Glaxosmithkline and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: methoxamine hydrochloride

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Bulk Api Vendors: see list20
Clinical Trials: see list2,252
Patent Applications: see list241
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:methoxamine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
VASOXYL
methoxamine hydrochloride
INJECTABLE;INJECTION006772-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
VASOXYL
methoxamine hydrochloride
INJECTABLE;INJECTION006772-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Covington
Cerilliant
Deloitte
Argus Health
Accenture
US Army
Cipla
Merck
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot